UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The complex pathway to United States Food and Drug Administration approval of Smoflipid

JPEN. Journal of parenteral and enteral nutrition, 2022-05, Vol.46 (4), p.748-751

Tabor, Edward

2022

Volltextzugriff (PDF)

Tutorial on How the US Food and Drug Administration Regulates Parenteral Nutrition Products

JPEN. Journal of parenteral and enteral nutrition, 2020-02, Vol.44 (2), p.174-181

Tabor, Edward

2020

Volltextzugriff (PDF)

Emerging Viruses in Human Populations

Tabor, Edward

1, 2006

Volltextzugriff (PDF)

Current Status of Multi‐Trace Element Products for Parenteral Nutrition in the United States

Nutrition in clinical practice, 2019-08, Vol.34 (4), p.487-488

Tabor, Edward

2019

Volltextzugriff (PDF)

Prepublication culture in clinical research

The Lancet (British edition), 2016-02, Vol.387 (10020), p.750-750

Tabor, Edward

2016

Volltextzugriff (PDF)

Pathogenesis of hepatitis B virus-associated hepatocellular carcinoma

Hepatology research, 2007-09, Vol.37 (s2), p.S110-S114

Tabor, Edward

2007

Volltextzugriff (PDF)

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

Transfusion (Philadelphia, Pa.), 2003-06, Vol.43 (6), p.788-798

2003

Volltextzugriff (PDF)

Comment on “Gut Microbiome: What We Do and Don’t Know”

Nutrition in clinical practice, 2016-06, Vol.31 (3), p.416-416

Tabor, Edward

2016

Volltextzugriff (PDF)

Infections by hepatitis B surface antigen gene mutants in Europe and North America

Journal of medical virology, 2006, Vol.78 (S1), p.S43-S47

Tabor, Edward

2006

Volltextzugriff (PDF)

As the FDA Begins to Address New Types of Lipid Emulsions for Parenteral Nutrition: Using the Basis for Approvals in Past Years as a Springboard for Discussion

Nutrition in clinical practice, 2013-12, Vol.28 (6), p.770-772

Tabor, Edward

2013

Volltextzugriff (PDF)

As the FDA Begins to Address New Types of Lipid Emulsions for Parenteral Nutrition

Nutrition in clinical practice, 2013-12, Vol.28 (6), p.770-772

Tabor, Edward

2013

Volltextzugriff (PDF)

SEN virus: epidemiology and characteristics of a transfusion-transmitted virus

Transfusion (Philadelphia, Pa.), 2005-07, Vol.45 (7), p.1084-1088

2005

Volltextzugriff (PDF)

Food and Drug Administration Requirements for Clinical Studies in Pediatric Patients

Therapeutic innovation & regulatory science, 2015-09, Vol.49 (5), p.666-672

Tabor, Edward

2015

Volltextzugriff (PDF)

Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis

The New England journal of medicine, 2021-04, Vol.384 (15), p.1474-1476

2021

Volltextzugriff (PDF)

Erratum: Review of Translational Medicine and Drug Discovery

Drug information journal, 2012-05, Vol.46 (3), p.378-378

Tabor, Edward

2012

Volltextzugriff (PDF)

Infections by hepatitis B surface antigen gene mutants in europe and North America: HIV variants and hepatitis B surface antigen mutants: diagnostic challenges for immunoassays

Journal of medical virology, 2006, Vol.78

TABOR, Edward

2006

Volltextzugriff (PDF)

Overview of the FDA Amendments Act of 2007: Its Effect on the Drug Development Landscape

Drug information journal, 2010-07, Vol.44 (4), p.469-475

2010

Volltextzugriff (PDF)

Persistence of antibody after hepatitis B vaccine and the question of boosters

Hepatology (Baltimore, Md.), 2005-04, Vol.41 (4), p.940; author reply 941-940

Tabor, Edward

2005

Volltextzugriff (PDF)

Bacteria by the Book [with Response]

Science (American Association for the Advancement of Science), 2008-11, Vol.322 (5903), p.853-854

2008

Volltextzugriff (PDF)

Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines

Journal of medical virology, 1992-12, Vol.38 (4), p.235-239

1992

Volltextzugriff (PDF)

Recombinant DNA Trials

Applied clinical trials, 2009-09, Vol.18 (9), p.44

2009

Volltextzugriff (PDF)

Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma

Journal of medical virology, 1994-04, Vol.42 (4), p.357-365

Tabor, Edward

1994

Volltextzugriff (PDF)

HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma

Journal of viral hepatitis, 2005-05, Vol.12 (3), p.325-329

2005

Volltextzugriff (PDF)

Carl Van Vechten's "Nigger Heaven": Envisioning and Reinventing American Transatlantic Bohemia in Harlem

Tabor, Edward N

2014

Volltextzugriff (PDF)

Potential risks of blood donation during pregnancy for autologous transfusion

Transfusion (Philadelphia, Pa.), 1990-01, Vol.30 (1), p.76-76

Tabor, Edward

1990

Volltextzugriff (PDF)

1 – 25 von 245

Menü

Weitere Dienste

Einstellungen

The complex pathway to United States Food and Drug Administration approval of Smoflipid

Tutorial on How the US Food and Drug Administration Regulates Parenteral Nutrition Products

Emerging Viruses in Human Populations

Current Status of Multi‐Trace Element Products for Parenteral Nutrition in the United States

Prepublication culture in clinical research

Pathogenesis of hepatitis B virus-associated hepatocellular carcinoma

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

Comment on “Gut Microbiome: What We Do and Don’t Know”

Infections by hepatitis B surface antigen gene mutants in Europe and North America

As the FDA Begins to Address New Types of Lipid Emulsions for Parenteral Nutrition: Using the Basis for Approvals in Past Years as a Springboard for Discussion

As the FDA Begins to Address New Types of Lipid Emulsions for Parenteral Nutrition

SEN virus: epidemiology and characteristics of a transfusion-transmitted virus

Food and Drug Administration Requirements for Clinical Studies in Pediatric Patients

Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis

Erratum: Review of Translational Medicine and Drug Discovery

Infections by hepatitis B surface antigen gene mutants in europe and North America: HIV variants and hepatitis B surface antigen mutants: diagnostic challenges for immunoassays

Overview of the FDA Amendments Act of 2007: Its Effect on the Drug Development Landscape

Persistence of antibody after hepatitis B vaccine and the question of boosters

Bacteria by the Book [with Response]

Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines

Recombinant DNA Trials

Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma

HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma

Carl Van Vechten's "Nigger Heaven": Envisioning and Reinventing American Transatlantic Bohemia in Harlem

Potential risks of blood donation during pregnancy for autologous transfusion

Suchergebnisse filtern